Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.


Funktionen

  • Privatdozent/in, Zentrum für Chirurgie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Gliga, Smaranda; Fiedler, Melanie; Dornieden, Theresa; Achterfeld, Anne; Paul, Andreas; Horn, Peter; Herzer, Kerstin; Lindemann, Monika
    Comparison of three cellular assays to predict the course of CMV infection in liver transplant recipients
    In: Vaccines Jg. 9 (2021) Nr. 2, S. 88
  • Wedemeyer, Heiner; Herzer, Kerstin; Serfert, Yvonne; Taubert, Richard; Trautwein, Christian; Eurich, Dennis; Strassburg, Christian P.; Lang, Melanie; Weiss, Karl Heinz; Berg, Thomas; Galle, Peter R.; Heinzow, Hauke; Zeuzem, Stefan
    Declining Numbers of Hepatitis C Virus-Associated Liver Transplantations in Germany
    In: Deutsches Ärzteblatt international Jg. 118 (2021) Nr. 46, S. 797 - 798
  • Rashidi-Alavijeh, Jassin; Crämer, Jens Christoph; Sauter, Helena Louisa; Willuweit, Katharina; Straub, Katja; Wedemeyer, Heiner; Herzer, Kerstin
    Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant
    In: Transplant Infectious Disease Jg. 23 (2021) Nr. 3, e13553
  • Willuweit, Katharina; Frey, Alexandra; Hörster, Anne; Saner, Fuat; Herzer, Kerstin
    Real-World Administration of Once-Daily MeltDose® Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation
    In: Journal of Clinical Medicine (JCM) Jg. 10 (2021) Nr. 1, 124
  • Rashidi-Alavijeh, Jassin; Straub, Katja; Achterfeld, Anne; Wedemeyer, Heiner; Willuweit, Katharina; Herzer, Kerstin
    Safety and efficacy of tenofovir alafenamide in liver transplant recipients : A single center experience
    In: Transplant Infectious Disease Jg. 23 (2021) Nr. 3, S. e13522
  • Herzer, Kerstin; Sterneck, Martina; Welker, Martin-Walter; Nadalin, Silvio; Kirchner, Gabriele; Braun, Felix; Malessa, Christina; Herber, Adam; Pratschke, Johann; Weiss, Karl Heinz; Jaeckel, Elmar; Tacke, Frank
    Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany
    In: Journal of Clinical Medicine (JCM) Jg. 9 (2020) Nr. 11, 3570
  • Knop, Viola; Mauss, Stefan; Goeser, Tobias; Geier, Andreas; Zimmermann, Tim; Herzer, Kerstin; Postel, Nils; Friedrich-Rust, Mireen; Hofmann, Wolf Peter; Wedemeyer, Heiner; German Hepatitis C‐Registry
    Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy : Results from the German Hepatitis C-Registry
    In: Journal of Viral Hepatitis Jg. 27 (2020) Nr. 7, S. 690 - 698
  • Willuweit, Katharina; Frey, Alexandra; Bieniek, Lisa; Heinold, Andreas; Büchter, Matthias; Horn, Peter; Wedemeyer, Heiner; Herzer, Kerstin
    HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level
    In: BMC Gastroenterology Jg. 20 (2020) Nr. 1, S. 288
  • Gerken, Guido; Walker, Andreas; Timm, Jörg; Frey, Alexandra; Wedemeyer, Heiner; Herzer, Kerstin
    An mTor-based immunosuppression reduces the antiviral efficacy of NS3/4A and NS5A inhibitors for HCV genotype 1b treatment in vitro
    In: Journal of Hepatology Jg. 70 (2019) Nr. 1 Suppl., S. e829
  • Wedemeyer, Heiner; Herzer, Kerstin; Hörster, Anne; Saner, Fuat; Frey, Alexandra
    Application of an extended-release tacrolimus formulation allows dose reduction and stabilizes graft function after liver transplantation
    In: Journal of Hepatology Jg. 70 (2019) Nr. 1 Suppl., S. e557 - e558
  • Willuweit, Katharina; Bezinover, Dmitri; Herzer, Kerstin; Nowak, Knut M.; Paul, Andreas; Saner, Fuat
    Efficacy of IgM-enriched Immunoglobulin for Vasopressor-resistant Vasoplegic Shock After Liver Transplantation
    In: Transplantation Jg. 103 (2019) Nr. 2, S. 381 - 386
  • Dehnen, Dorothea; Herwig, Anna; Herzer, Kerstin; Weltermann, Birgitta
    Improving the vaccination status of liver transplant patients : Effectiveness of personally addressing patients and written recommendations to family physicians after 3 years
    In: Transplant Infectious Disease Jg. 21 (2019) Nr. 5, S. e13140
  • Kaulfuß, M.; Herzer, Kerstin; Witzke, Oliver
    KDIGO-Leitlinie zu Prävention, Diagnostik, Evaluation und Therapie der Hepatitis-C-Virus-Infektion bei chronischer Nierenerkrankung : Deutsche Übersetzung und Kurzfassung
    In: Der Nephrologe Jg. 14 (2019) Nr. 1, S. 46 - 50
  • Straub, Katja; Husen, Peri; Baba, Hideo Andreas; Trippler, Martin; Wedemeyer, Heiner; Herzer, Kerstin
    Promyelocytic leukemia protein deficiency leads to spontaneous formation of liver tumors in hepatitis C virus transgenic mice
    In: Cancer Medicine Jg. 8 (2019) Nr. 8, S. 3793 - 3802
  • Husen, Peri; Straub, K.; Willuweit, Katharina; Hagemann, Anna; Wedemeyer, Heiner; Bachmann, Hagen Sjard; Herzer, Kerstin
    SNPs Within the MTOR Gene Are Associated With an Increased Risk of Developing De Novo Diabetes Mellitus Following the Administration of Everolimus in Liver Transplant Recipients
    In: Transplantation Proceedings Jg. 51 (2019) Nr. 6, S. 1962 - 1971
  • Friebus-Kardash, Justa; Gäckler, Anja; Kribben, Andreas; Witzke, Oliver; Wedemeyer, Heiner; Treckmann, Jürgen-Walter; Herzer, Kerstin; Eisenberger, Ute
    Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients
    In: Transplant Infectious Disease Jg. 21 (2019) Nr. 5, S. e13146
  • Bedreli, Sotiria; Straub, Katja; Achterfeld, Anne; Willuweit, Katharina; Katsounas, Antonios; Saner, Fuat; Wedemeyer, Heiner; Herzer, Kerstin
    The Effect of Immunosuppression on Coagulation After Liver Transplantation
    In: Liver Transplantation Jg. 25 (2019) Nr. 7, S. 1054 - 1065
  • Eisenberger, Ute; Friebus-Kardash, Justa; Guberina, Hana; Kribben, Andreas; Witzke, Oliver; Willuweit, Katharina; Gerken, Guido; Herzer, Kerstin
    Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function.
    In: Transplantation Direct Jg. 5 (2019) Nr. 1, S. e419
  • Herzer, Kerstin; Eisenberger, Ute
    Verwendung HBV- oder HCV-infizierter Spenderorgane bei der Leber- und Nierentransplantation
    In: Der Gastroenterologe Jg. 14 (2019) Nr. 4, S. 260 - 268
  • Herzer, Kerstin; Gerken, Guido; Kroy, Daniela; Tacke, Frank; Plewe, Julius; Eurich, Dennis; Spengler, Ulrich; Strassburg, Christian P.; Welker, Martin-Walter; Pischke, Sven; Sterneck, Martina; Mehrabi, Arianeb; Weiss, Karl Heinz; Herber, Adam; Berg, Thomas; Zimmermann, Tim; Galle, Peter R.; Heinzow, Hauke; Schmidt, Hartmut; Markova, Antoaneta; Serfert, Yvonne; Manns, Michael P.; Zeuzem, Stefan; Wedemeyer, Heiner
    Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany
    In: Journal of Hepatology Jg. 69 (2018) Nr. 4, S. 982 - 984
  • Beckebaum, Susanne; Herzer, Kerstin; Bauhofer, Artur; Gelson, William; De Simone, Paolo; de Man, Robert; Engelmann, Cornelius; Müllhaupt, Beat; Vionnet, Julien; Salizzoni, Mauro; Volpes, Riccardo; Ercolani, Giorgio; De Carlis, Luciano; Angeli, Paolo; Burra, Patrizia; Dufour, Jean-François; Rossi, Massimo; Cillo, Umberto; Neumann, Ulf; Fischer, Lutz; Niemann, Gabriele; Toti, Luca; Tisone, Guiseppe
    Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis
    In: Annals of Transplantation Jg. 23 (2018) S. 789 - 801
  • Herzer, Kerstin; Frey, Alexandra; Walker, Andreas; Timm, Jörg; Gerken, Guido; Piras-Straub, Katja
    The influence of immunosuppressants on direct-acting antiviral therapy is dependent on the hepatitis C virus genotype
    In: Transplant Infectious Disease Jg. 20 (2018) Nr. 1, S. e12803
  • Durr, M.; Budde, K.; Hofmann, J.; Eisenberger, Ute; Herzer, Kerstin; Sterneck, M.; Gottlieb, J.; Schulz, U.; Halleck, F.
    Accidental Transmission of Hepatitis C (HCV) Virus from an Organ Donor to Five Transplant Recipients : Early Treatment with Direct Acting Antivirals Successfully Prevents HCV-Infection
    In: Transplant International Jg. 30 (2017) Nr. Suppl. 4 SI, S. 28 Abstract P02
  • Halleck, Fabian; Budde, Klemens; Hofmann, Joerg; Eisenberger, Ute; Herzer, Kerstin; Stemeck, Martina; Gottlieb, Jens; Schulz, Uwe; Durr, Michael
    Accidental Transmission of Hepatitis C (HCV) Virus from an Organ Donor to five Transplant Recipients : Early treatment with direct acting Antivrials successfully Prevents Chronic HCV Infection
    In: Transplant International Jg. 30 (2017) Nr. Suppl. 2 SI, S. 37 - 38 Abstract OS092
  • Gliga, S.; Fiedler, Melanie; Herzer, Kerstin; Witzke, Oliver; Krawczyk, Adalbert; Korth, Johannes; Horn, Peter; Dittmer, Ulf; Lindemann, Monika
    CMV elispot assays are superior to the quantiferon CMV assay to predict protection from CMV reactivation in kidney ans liver transplant recipients
    In: HLA: Immune Response Genetics (Human Leukocyte Antigens) Jg. 89 (2017) Nr. 6, S. 375
  • Beckebaum, Susanne; Herzer, Kerstin; Bauhofer, A.; Gelson, W.; Desimone, P.; Deman, R.; Mullhaupt, B.; Vionnet, J.; Tisone, G.
    Effectiveness of subcutaneous & intravenous Hepatitis B immunoglobulin to prevent reinfection after liver transplantation : Long-term results from an international multicenter non-interventional study
    In: Transplant International Jg. 30 (2017) Nr. S2, Special Issue: Abstracts of the 18th Congress of the European Society for Organ Transplantation, 24‐27 September 2017, Barcelona, Spain, S. 40
  • Frey, A.; Ecker, E.-M.; Piras-Straub, K.; Walker, Andreas; Hofmann, T.G.; Timm, Jörg; Singer, Bernhard B.; Gerken, Guido; Herzer, Kerstin
    Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo
    In: Transplantation Proceedings Jg. 49 (2017) Nr. 8, S. 1947 - 1955
  • Forns, Xavier; Berenguer, Marina; Herzer, Kerstin; Sterneck, Martina; Donato, Maria Francesca; Andreone, Pietro; Fagiuoli, Stefano; Cieciura, Tomasz; Durlik, Magdalena; Calleja, Jose Luis; Mariño, Zoe; Shukla, Umesh; Verbinnen, Thierry; Lenz, Oliver; Ouwerkerk-Mahadevan, Sivi; Peeters, Monika; Janssen, Katrien; Kalmeijer, Ronald; Jessner, Wolfgang
    Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation : The Phase II SATURN study
    In: Transplant Infectious Disease Jg. 19 (2017) Nr. 3, S. e12696
  • Kocabayoglu, Peri; Piras-Straub, Katja; Gerken, Guido; Paul, Andreas; Herzer, Kerstin
    Expression of fibrogenic markers in tumor and tumor-surrounding tissue at time of transplantation correlates with recurrence of hepatocellular carcinoma in patients undergoing liver transplantation
    In: Annals of Transplantation Jg. 22 (2017) S. 446 - 454
  • Eisenberger, Ute; Friebus-Kardash, J.; Guberina, H.; Kribben, Andreas; Witzke, Oliver; Achterfeld, A.; Gerken, Guido; Herzer, Kerstin
    Feasibility of Elabasvir/Grazoprevir for Trearment of Chronic Hepatitis C Virus Infection in Renal Transplant Recipients with Impaired Allograft Function
    In: Transplant International Jg. 30 (2017) Nr. Suppl 4 SI, S. 28 Abstract P01
  • Frey, A.; Walker, A.; Trippler, M.; Gerken, Guido; Herzer, Kerstin
    How do MTOR Inhibitors modulate HCV replication activity : an approach by whole genome analysis
    In: Transplant International Jg. 30 (2017) Nr. S4, Special Issue: Abstracts of the 26th Annual Meeting of the German Transplantation Society, Bonn, Germany, 25–28 October 2017, S. 38
  • Willuweit, Katharina; Heinold, Andreas; Rashidi-Alavijeh, Jassin; Heinemann, Falko M.; Horn, Peter; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    Immunosuppression with mTOR inhibitors prevents the development of donor-specific antibodies after liver transplant
    In: Clinical Transplantation Jg. 31 (2017) Nr. 6, S. e12974
  • Herzer, Kerstin; Gerken, Guido; Kroy, D.; Tacke, F.; Plewe, J.; Eurich, D.; Spengler, U.; Strassburg, C. P.; Welker, M. W.; Pischke, S.; Sterneck, M.; Mehrabi, A.; Weiss, K. H.; Herber, A.; Berg, T.; Zimmermann, T.; Galle, P. R.; Heinzow, H.; Schmidt, H.; von Hahn, T.; Serfert, Y.; Manns, M. P.; Zeuzem, S.; Wedemeyer, Heiner
    Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany
    In: Transplant International Jg. 30 (2017) Nr. Suppl. 4, S. 18 - 18
  • Herzer, Kerstin; Gerken, Guido; Kroy, D.; Tacke, F.; Plewe, J.; Eurich, D.; Spengler, U.; Strassburg, C. P.; Welker, M. W.; Pischke, S.; Sterneck, M. R.; Mehrabi, A.; Weiss, K. H.; Herber, A.; Berg, T.; Zimmermann, T.; Galle, P. R.; Heinzow, H.; Schmidt, H. H.; von Hahn, T.; Serfert, Y.; Manns, M. P.; Zeuzem, S.; Wedemeyer, Heiner; German Hepatitis C-Registry
    Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany
    In: Hepatology Jg. 66 (2017) Nr. S1, Special Issue: The 68th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2017, S. 877A
  • Willuweit, K.; Polewsky, L.; Heinold, Andreas; Frey, A.; Horn, Peter; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    Impact of donor specific antibodies following liver transplantation
    In: Transplant International Jg. 30 (2017) Nr. Suppl. 4, S. 14 - 14
  • Willuweit, Katharina; Canbay, Aliekber; Gerken, Guido; Timm, Jörg; Paul, Andreas; Treckmann, Jürgen-Walter; Herzer, Kerstin
    Liver transplantation from HCV RNA-positive donors in the era of interferon-free HCV therapeutics : A re-examination of the situation
    In: Minerva Gastroenterologica e Dietologica Jg. 63 (2017) Nr. 1, S. 55 - 61
  • Herzer, Kerstin; Welzel, Tania M.; Spengler, Ulrich; Hinrichsen, Holger; Klinker, Hartwig; Berg, Thomas; Ferenci, Peter; Peck-Radosavljevic, Markus; Inderson, Akin; Zhao, Yue; Jimenez-Exposito, Maria Jesus; Zeuzem, Stefan
    Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver disease
    In: Transplant International Jg. 30 (2017) Nr. 3, S. 243 - 255
  • Piras-Straub, K.; Kocabayoglu, P.; Baba, Hideo Andreas; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    Sofosbuvir impairs proliferation of hepatocytes in vitro and in vivo
    In: Transplant International Jg. 30 (2017) Nr. Suppl. 4, S. 17 - 17
  • Eisenberger, Ute; Guberina, Hana; Willuweit, Katharina; Bienholz, Anja; Kribben, Andreas; Gerken, Guido; Witzke, Oliver; Herzer, Kerstin
    Successful treatment of chronic hepatitis C virus infection with sofosbuvir and ledipasvir in renal transplant recipients
    In: Transplantation Jg. 101 (2017) Nr. 5, S. 980 - 986
  • Halleck, Fabian; Budde, Klemens; Duerr, Michael; Staeck, Oliver; Hofmann, Joerg; Eisenberger, Ute; Herzer, Kerstin; Sterneck, Martina; Gottlieb, Jens; Schulz, Uwe
    Transplanting HCV-infected kidneys into uninfected recipients
    In: The New England Journal of Medicine Jg. 377 (2017) Nr. 11, S. 1103 - 1104
  • Piras-Straub, Katja; Khairzada, Khaleda; Kocabayoglu, Peri; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    A -1573T>C SNP within the human TRAIL promoter determines TRAIL expression and HCC tumor progression
    In: Cancer Medicine Jg. 5 (2016) Nr. 10, S. 2942 - 2952
  • Hildebrand, Tatiana; Pannicke, Nadine; Dechene, Alexander; Gotthardt, Daniel N; Kirchner, Gabriele; Reiter, Florian P; Sterneck, Martina; Herzer, Kerstin; Lenzen, Henrike; Rupp, Christian; Barg-Hock, Hannelore; de Leuw, Philipp; Teufel, Andreas; Zimmer, Vincent; Lammert, Frank; Sarrazin, Christoph; Spengler, Ulrich; Rust, Christian; Manns, Michael P; Strassburg, Christian P; Schramm, Christoph; Weismüller, Tobias J
    Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis : A retrospective multicenter analysis
    In: Liver Transplantation Jg. 22 (2016) Nr. 1, S. 42 - 52
  • Fontana, Robert; Berg, Christoph; Knop, Viola; Stauber, Rudolf E.; Chacko, Kristina R.; Herzer, Kerstin; Londono, Maria-Carlota; Joshi, Shobha; Prieto, Martin; Moreno-Zamora, Ana
    Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection
    In: Liver Transplantation Jg. 22 (2016) Nr. 4, S. 446 - 458
  • Welzel, T. M.; Petersen, J.; Herzer, Kerstin; Ferenci, P.; Gschwantler, M.; Wedemeyer, H.; Berg, T.; Spengler, U.; Weiland, O.; van der Valk, M.; Rockstroh, J.; Peck-Radosavljevic, M.; Zhao, Y.; Jimenez-Exposito, M. J.; Zeuzem, S.
    Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
    In: Gut Jg. 65 (2016) Nr. 11, S. 1861 - 1870
  • Rashidi-Alavijeh, J; Heinold, Andreas; Willuweit, K; Baba, Hideo Andreas; Horn, Peter; Paul, Andreas; Witzke, Oliver; Gerken, Guido; Herzer, Kerstin
    Diagnostics and treatment of a severe humoral rejection after liver transplantation : donor-specific antibodies as a still underestimated cause of graft failure
    In: Zeitschrift für Gastroenterologie Jg. 54 (2016) Nr. 7, S. 647 - 652
  • Forns, Xavier; Samuel, Didier; Mutimer, David; Fagiuoli, Stefano; Navasa, Miquel; Agarwal, Kosh; Berenguer, Marina; Colombo, Massimo; Herzer, Kerstin; Nevens, Frederik; Daems, Bjorn; Janssen, Katrien; Ouwerkerk-Mahadevan, Sivi; Kimko, Holly; Lathouwers, Erkki; Witek, James; van Solingen-Ristea, Rodica
    Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C
    In: Annals of Hepatology Jg. 15 (2016) Nr. 4, S. 512 - 523
  • Zimmermann, T; Beckebaum, Susanne; Berg, C; Berg, T; Braun, F; Eurich, D; Herzer, Kerstin; Neumann, U; Rupp, C; Sterneck, M; Strassburg, C; Welker, M-W; Zachoval, R; Gotthardt, D N; Weigand, K; Schmidt, H; Wedemeyer, H; Galle, P R; Zeuzem, S; Sarrazin, C
    Empfehlungen zur antiviralen Therapie der chronischen Hepatitis C bei Patienten auf der Warteliste und nach Transplantation
    In: Zeitschrift für Gastroenterologie Jg. 54 (2016) Nr. 7, S. 665 - 684
  • Jahn, M.; Herzer, Kerstin; Witzke, Oliver
    Hepatitis C und Nierenerkrankungen
    In: Der Nephrologe Jg. 11 (2016) Nr. 5, S. 361 - 374
  • Herzer, Kerstin; Roeb, Elke
    Modernes Management und neue Herausforderungen bei Fettlebererkrankungen
    In: Klinikarzt Jg. 45 (2016) Nr. 12, S. 596 - 601
  • Herzer, Kerstin; Sterneck, Martina; Nashan, Björn; Zimmermann, T.; Schnitzbauer, Andreas A.; Scherer, Markus N.; Pascher, Andreas; Nadalin, Silvio; Lehner, Frank; Guba, Markus; Engelmann, Cornelius; Braun, Felix; Strassburg, Christian P.
    Selection and use of immunosuppressive therapies after liver transplantation : current German practice
    In: Clinical Transplantation Jg. 30 (2016) Nr. 5, S. 487 - 501
  • Weltermann, Birgitta; Herzer, Kerstin; Herwig, Anna; Dehnen, Dorothea
    Vaccination Status of Pneumococcal and Other Vaccines in 444 Liver Transplant Patients Compared to a Representative Population Sample
    In: Annals of Transplantation Jg. 21 (2016) S. 200 - 207
  • Herzer, Kerstin; Gerken, Guido
    When and How to Treat HCV Infection with the New Antivirals before or after Liver Transplantation
    In: Visceral Medicine Jg. 32 (2016) Nr. 4, S. 258 - 262
  • Reis, Henning; Wohlschläger, Jeremias; Hagemann, Sascha; Wenzel, Patricia; Bechmann, Lars Peter; Suttorp, Anna-Carinna; Schlattjan, Martin J; Herzer, Kerstin; Canbay, Aliekber; Baba, Hideo Andreas
    (Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allografts
    In: Liver International Jg. 35 (2015) Nr. 3, S. 905 - 913
  • Piras-Straub, K.; Paul, A.; Gerken, Guido; Herzer, Kerstin
    A GATA-1 binding site mutation leads to reduced TRAIL expression in human HCC
    In: Journal of Viral Hepatitis Jg. 22 (2015) Nr. S2, S. 131
  • Herzer, Kerstin; Welzel, T. M.; Ferenci, P.; Petersen, J.; Gschwantler, M.; Cornberg, M.; Berg, T.; Spengler, U.; Weiland, O.; van der Valk, M.; Klinker, H.; Rockstroh, J. K.; Schott, E.; Peck-Radosavljevic, M.; Zhao, Y.; Exposito, M. J. J.; Zeuzem, S.
    Daclatasvir in combination with sofosbuvir with or without ribavirin is safe and efficacious in liver transplant recipients with HCV recurrence : Interim results of a multicenter compassionate use program
    In: Hepatology Jg. 62 (2015) Nr. S1, S. 341A
  • Welzel, T. M.; Herzer, Kerstin; Ferenci, P.; Petersen, J.; Gschwantler, M.; Cornberg, M.; Berg, T.; Spengler, U.; Weiland, O.; Van der Valk, M.; Klinker, H.; Rockstroh, J.; Ingiliz, P.; Peck-Radosavljevic, M.; Jimenez-Exposito, M. J.; Zeuzem, S.
    Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease : Interim results of a multicenter compassionate use program
    In: Journal of Hepatology Jg. 62 (2015) Nr. Suppl. 2, S. 619 - S620
  • Welzel, T.; Herzer, Kerstin; Ferenci, P.; Petersen, J.; Gschwantler, M.; Cornberg, M.; Berg, T.; Spengler, U.; Weiland, O.; Van der Valk, M.; Klinker, H.; Rockstroh, J.; Ingiliz, P.; Peck-Radosavljevic, M.; Jimenez-Exposito, M. J.; Zeuzem, S.
    Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease : interim results of a compassionate use program
    In: Journal of Viral Hepatitis Jg. 22 (2015) Nr. Suppl. 3, S. 4 - 5
  • Rockstroh, J. K.; Welzel, T. M.; Ingiliz, P.; Petersen, J.; van der Valk, M.; Herzer, Kerstin; Ferenci, P.; Gschwantler, M.; Cornberg, M.; Berg, T.; Spengler, U.; Weiland, O.; Klinker, H.; Peck-Radosavljevic, M.; Zhao, Y.; Exposito, M. J. J.; Zeuzem, S.
    Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of chronic HCV in patients coinfected with HIV : Interim results of a multicenter compassionate use program
    In: Hepatology Jg. 62 (2015) Nr. Suppl. 1, S. 728A - 729A
  • Herzer, Kerstin; Papadopoulos-Köhn, Angela; Walker, Andreas; Achterfeld, Anne; Paul, Andreas; Canbay, Aliekber; Timm, Jörg; Gerken, Guido
    Daclatasvir, Simeprevir and Ribavirin as a Promising Interferon-Free Triple Regimen for HCV Recurrence after Liver Transplant
    In: Digestion Jg. 91 (2015) Nr. 4, S. 326 - 333
  • Papadopoulos-Köhn, Angela; Achterfeld, Anne; Paul, Andreas; Canbay, Aliekber; Timm, Jörg; Jochum, Christoph; Gerken, Guido; Herzer, Kerstin
    Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant
    In: Transplantation Jg. 99 (2015) Nr. 4, S. 841 - 847
  • Schumann, Alexandra; Fiedler, Melanie; Beckebaum, Susanne; Cicinnati, Vito; Herzer, Kerstin; Lenz, Veronika; Witzke, Oliver; Paul, Andreas; Roggendorf, Michael; Horn, Peter; Lindemann, Monika
    Donor- and recipient-derived immunity in ABO incompatible living-related liver transplantation
    In: Human Immunology Jg. 76 (2015) Nr. 9, S. 631 - 635
  • Piras-Straub, Katja; Khairzada, Khaleda; Gerken, Guido; Saner, Fuat; Treckmann, Jürgen-Walter; Paul, Andreas; Canbay, Aliekber; Herzer, Kerstin
    Glutamate Dehydrogenase and Alkaline Phosphatase as Very Early Predictors of Hepatocellular Carcinoma Recurrence after Liver Transplantation
    In: Digestion Jg. 91 (2015) Nr. 2, S. 117 - 127
  • Frey, A.; Ecker, E. M.; Piras-Straub, K.; Walker, Andreas; Hofmann, T.; Gerken, Guido; Herzer, Kerstin
    HCV replication activity is modified by mTor-inhibitors in vitro which is mediated by PML
    In: Journal of Viral Hepatitis Jg. 22 (2015) Nr. Suppl. 2, S. 69 - 70
  • Herzer, Kerstin; Gerken, Guido
    Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agents
    In: World Journal of Hepatology Jg. 7 (2015) Nr. 3, S. 532 - 538
  • Herzer, Kerstin; Papadopoulos-Köhn, Angela; Achterfeld, Anne; Canbay, Aliekber; Piras-Straub, Katja; Paul, Andreas; Walker, Andreas; Timm, Jörg; Gerken, Guido
    Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant
    In: World Journal of Hepatology Jg. 7 (2015) Nr. 9, S. 1287 - 1296
  • Forns, X.; Berenguer, M.; Herzer, Kerstin; Sterneck, M.; Donato, M. F.; Andreone, P.; Fagiuoli, S.; Cieciura, T.; Durlik, M.; Calleja, J. L.; Marino, Z.; Simion, A.; Shukla, U.; Verbinnen, T.; Lenz, O.; Ouwerkerk-Mahadevan, S.; Peeters, M.; Kalmeijer, R.; Witek, J.
    On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis c virus genotype 1b infection after orthotopic liver transplantation (OLT) : Interim data from the phase II saturn study
    In: Journal of Hepatology Jg. 62 (2015) Nr. Suppl. 2, S. S 191 - S192
  • Welzel, T. M.; Petersen, J.; Ferenci, P.; Gschwantler, M.; Herzer, Kerstin; Cornberg, M.; Schott, E.; Berg, T.; Spengler, U.; Weiland, O.; van der Valk, M.; Geier, A.; Rockstroh, J. K.; Peck-Radosavljevic, M.; Zhao, Y.; Exposito, M. J. J.; Zeuzem, S.
    Safety and efficacy of daclatasvir plus sofosbuvir with or without ribavirin for the treatment of chronic HCV genotype 3 infection : Interim results of a multicenter European compassionate use program
    In: Hepatology Jg. 62 (2015) Nr. S1, S. 225A - 226A
  • Piras-Straub, Katja; Khairzada, Khaleda; Trippler, Martin; Baba, Hideo Andreas; Kaiser, Gernot Maximil; Paul, Andreas; Canbay, Aliekber; Weber, Frank; Gerken, Guido; Herzer, Kerstin
    TRAIL expression levels in human hepatocellular carcinoma have implications for tumor growth, recurrence and survival
    In: International Journal of Cancer Jg. 136 (2015) Nr. 4, S. E154 - E160
  • Frey, A.; Ecker, E. M.; Piras-Straub, K.; Walker, A.; Hofmann, T.; Gerken, Guido; Herzer, Kerstin
    The tumor suppressor PML mediates everolimus- induced changes of the HCV replication activity
    In: Journal of Hepatology Jg. 62 (2015) Nr. Suppl. 2, S. 582
  • Herzer, Kerstin; Gerken, Guido
    Therapie der Hepatitis C bei Patienten mit Zirrhose sowie vor und nach Lebertransplantation
    In: Der Gastroenterologe Jg. 10 (2015) Nr. 4, S. 297 - 304
  • Herzer, Kerstin; Gerken, Guido; Hoffmann, Thomas
    Hepatitis C-associated liver carcinogenesis : Role of PML nuclear bodies
    In: World Journal of Gastroenterology Jg. 20 (2014) Nr. 35, S. 12367 - 12371
  • Kahraman, Alisan; Herzer, Kerstin
    Laboratory monitoring after liver transplantation
    In: Gastroenterologe Jg. 9 (2014) Nr. 2, S. 112 - 116
  • Hilgard, Philip Alexander; Dechene, Alexander; Canbay, Aliekber; Herzer, Kerstin; Schlaak, Jörg Friedrich; Treichel, Ulrich; Gassel, Andrea M.; Baba, Hideo Andreas; Zöpf, Thomas
    Mini-laparoscopy is superior in detecting liver cirrhosis and metastases in liver cancer : an over 10-year experience in 1,788 cases
    In: Digestion Jg. 89 (2014) Nr. 2, S. 156 - 164
  • Amrillaeva, V.; Hoyer, D.; Gallinat, Anja; Herzer, Kerstin; Canbay, Aliekber; Treckmann, Jürgen-Walter; Mathe, Zoltan; Paul, Andreas; Saner, Fuat
    Retransplantation for Hepatitis C Recurrence : Should We Do It?
    In: American Journal of Transplantation Jg. 14 (2014) Nr. Suppl. 3, S. 705
  • Teufel, A.; Sarrazin, C.; Pannicke, N.; Kirchner, G.; Zimmer, V.; Lenzen, Henrike; Schramm, C.; Weismüller, T.J.; Rust, C.; Lammert, F.; de Leuw, P.; Horn, T.; Dechene, Alexander; Sterneck, M.; Reiter, F.P.; Strassburg, C.P.; Herzer, Kerstin; Gotthardt, D.; Manns, M.P.; Barg-Hock, H.; Spengler, Ulf
    Biliary strictures and recurrent disease after liver transplantation for primary sclerosing cholangitis - a large, multicenter cohort analysis with long-term follow-up
    In: Journal of Hepatology Jg. 58 (2013) Nr. Suppl. 1, S. S42 - S43
  • Herzer, Kerstin; Papadopoulos-Kohn, A.; Buchter, M.; Canbay, Aliekber; Paul, Andreas; Jochum, Christoph; Gerken, Guido
    Daily low-dose Tacrolimus (TAC) is a save and efficient immunosuppressive regimen during triple drug therapy post liver transplant
    In: Der Internist Jg. 54 (2013) Nr. Suppl. 1, S. 32 - 33
  • Herzer, Kerstin; Papadopoulos-Köhn, A.; Paul, Andreas; Gerken, Guido
    Daily low-dose tacrolimus (TAC) is a safe and efficient immunosuppressive regimen during HCV triple drug therapy post liver transplant - A 24 weeks interim analysis
    In: Transplant International Jg. 26 (2013) Nr. Suppl. 1, S. 6
  • Fingas, Christian; Altinbas, Akif; Schlattjan, Martin; Beilfuss, Anja; Sowa, Jan-Peter; Sydor, Svenja; Bechmann, Lars Peter; Ertle, Judith; Akkiz, Hikmet; Herzer, Kerstin; Paul, Andreas; Gerken, Guido; Baba, Hideo Andreas; Canbay, Aliekber
    Expression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinoma
    In: Digestion Jg. 87 (2013) Nr. 3, S. 176 - 181
  • Kirchner, G.; Herzer, Kerstin; Horn, T.; Spengler, Ulf; Gotthardt, D.; Manns, M.P.; Strassburg, C.P.; Pannicke, N.; Lenzen, Henrike; Dechene, Alexander; Schramm, C.; Barg-Hock, H.; Sterneck, M.; Weismüller, T.J.
    Extrahepatic malignancies after liver transplantation for primary sclerosing cholangitis - a long-term follow-up observational study of a large, multicenter cohort
    In: Journal of Hepatology Jg. 58 (2013) Nr. Suppl. 1, S. S395
  • Herzer, Kerstin; Papadopoulos-Köhn, Angela; Timm, Jörg; Paul, Andreas; Jochum, Christoph; Gerken, Guido
    HCV-Reinfektion nach Lebertransplantation : Management und erste Ergebnisse mit der Telaprevir-basierten Triple-Therapie
    In: Deutsche Medizinische Wochenschrift: DMW Jg. 138 (2013) Nr. 36, S. 1759 - 1764
  • Herzer, Kerstin; Paul, Andreas; Gerken, Guido
    Lebertransplantation - Wo stehen wir heute?
    In: Deutsche Medizinische Wochenschrift - DMW Jg. 138 (2013) Nr. 28-29, S. 1471 - 1477
  • Krawczyk, Adalbert; Roggendorf, Hedwig; Ludwig, Charlotte; Herzer, Kerstin; Gerken, Guido; Horn, Peter; Roggendorf, Michael; Lindemann, Monika
    Therapeutic vaccination of a liver transplant recipient suffering from fulminant hepatitis B during pregnancy
    In: Liver Transplantation Jg. 19 (2013) Nr. 12, S. 1411 - 1412
  • Herzer, Kerstin; Carbow, Anna; Sydor, Svenja; Sowa, Jan-Peter; Biesterfeld, Stefan; Hofmann, Thomas-Georg; Galle, Peter-Robert; Gerken, Guido; Canbay, Aliekber
    Deficiency of the Promyelocytic Leukemia Protein Fosters Hepatitis C-Associated Hepatocarcinogenesis in Mice
    In: PLoS ONE Jg. 7 (2012) Nr. 9, S. e44474
  • Herzer, K.; Müller, Stefan; Antoch, G.; Hilgard, Philip Alexander
    Locoregional therapy for hepatocellular carcinoma : Radioembolization with yttrium-90 microspheres
    In: Minerva Gastroenterologica e Dietologica Jg. 57 (2011) Nr. 3, S. 287 - 298
  • Ertle, Judith; Dechene, Alexander; Sowa, Jan-Peter; Penndorf, Volker; Herzer, Kerstin; Kaiser, Gernot Maximil; Schlaak, Jörg Friedrich; Gerken, Guido; Syn, Wing-Kin; Canbay, Aliekber
    Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
    In: International Journal of Cancer Jg. 128 (2011) Nr. 10, S. 2436 - 2443
  • Herzer, Kerstin; Kneiseler, Guntje; Bechmann, Lars Peter; Post, Felix; Schlattjan, Martin; Sowa, Jan-Peter; Neumann, Till; Marggraf, Günter; Erbel, Raimund; Gerken, Guido; Canbay, Aliekber; Jochum, Christoph
    Onset of heart failure determines the hepatic cell death pattern
    In: Annals of Hepatology Jg. 10 (2011) Nr. 2, S. 174 - 179
  • Wree, Alexander; Dechene, Alexander; Herzer, Kerstin; Hilgard, Phillip; Syn, Wing-Kin; Gerken, Guido; Canbay, Aliekber
    Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver Injury
    In: Digestion Jg. 84 (2011) Nr. 1, S. 54 - 59
  • Kneiseler, G.; Herzer, Kerstin; Marggraf, Günter; Gerken, Guido; Canbay, Aliekber
    Die Interaktion zwischen Leber und Herz
    In: Zeitschrift für Herz-, Thorax- und Gefässchirurgie Jg. 24 (2010) Nr. 6, S. 334 - 340
  • Herzer, Kerstin; Post, F.; Canbay, Aliekber; Gerken, Guido
    Pulmonale Affektion bei fortgeschrittener Lebererkrankung – hepatopulmonales Syndrom und portopulmonale Hypertonie
    In: Medizinische Klinik Jg. 105 (2010) Nr. 12, S. 916 - 923
  • Vorworte / Nachworte

  • Herzer, Kerstin; Fingas, Christian; Canbay, Aliekber
    Does ursodeoxycholic acid exert a protective effect on liver grafts in orthotopic liver transplantation?
    In: Digestion Jg. 86 (2012) Nr. 3, S. 206 - 207
  • Abstracts

  • Hagemann, A.; Husen, P.; Straub, K.; Willuweit, Katharina; Wedemeyer, Heiner; Bachmann, Hagen Sjard; Herzer, Kerstin;
    MTOR polymorphisms and de novo diabetes mellitus in liver transplantation patients treated with everolimus
    87th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) ; 1 March – 3 March 2021, Digital,
    In: Naunyn-Schmiedeberg's Archives of Pharmacology Jg. 394 (2021) Nr. Suppl. 1, S. S25
  • Frey, A.; Trippler, Martin; Gerken, Guido; Herzer, Kerstin
    CCNT1 mediates mTor inhibitor related antiviral effects in HCV genotype 2a
    In: Journal of Hepatology Jg. 68 (2018) Nr. Suppl. 1, S. 136
  • Knop, Viola; Mauss, Stefan; Goeser, Tobias; Geier, Andreas; Zimmermann, Tim; Herzer, Kerstin; Postel, Nils; Hofmann, Wolf Peter
    Dynamics of Liver Stiffness By Transient Elastography in Patients with Chronic Hepatitis C (HCV) Infection Receiving Direct Acting Antiviral Therapy-Results from the German Hepatitis C-Registry (DHC-R)
    In: Hepatology Jg. 68 (2018) Nr. Suppl. 1, S. 424A
  • Friebus-Kardash, J.; Gäckler, Anja; Kribben, Andreas; Witzke, Oliver; Wedemeyer, Heiner; Treckmann, Jürgen-Walter; Herzer, Kerstin; Eisenberger, Ute;
    Successful early treatment of HCV viremia after transplantation of HCV positive renal allografts into HCV negative recipients
    27th Annual Meeting of the German Transplantation Society, Berlin, Germany, 7–10 November 2018,
    In: Transplant International Jg. 31 (2018) Nr. Suppl. 5, S. 11
  • Bedreli, Sotiria; Piras-Straub, K.; Achterfeld, Anne; Katsounas, Antonios; Saner, Fuat; Gerken, Guido; Herzer, Kerstin
    The effect of immunosuppression on coagulation in patients after liver transplantation
    In: Journal of Hepatology Jg. 68 (2018) Nr. Suppl. 1, S. 386 - S387
  • Eisenberger, Ute; Friebus-Kardash, Justa; Rohn, Hana; Kribben, Andreas; Witzke, Oliver; Gäckler, Anja; Willuweit, Katharina; Gerken, Guido; Herzer, Kerstin
    Treatment with Grazoprevir/Elbasvir for renal transplant recipients with chronic Hepatitis C Virus Infection and impaired allograft function
    In: Nephrology Dialysis Transplantation (NDT) Jg. 33 (2018) Nr. Suppl_1, S. i602 - i603
  • Herzer, Kerstin; Welzel, T.; Ferenci, P.; Petersen, J.; Gschwantler, M.; Cornberg, M.; Berg, T.; Spengler, U.; Weiland, O.; Van der Valk, M.; Klinker, H.; Rockstroh, J.; Schott, E.; Peck-Radosavljevic, M.; Zhao, Y.; Exposito, M. J. J.; Zeuzem, S.
    Daclatasvir plus Sofosbuvir +/- Ribavirin in Liver Transplant Recipients with HCV Recurrence : Interim Results of a European Multicenter Compassionate Use Program
    In: Transplantation Jg. 100 (2016) Nr. Suppl. 5, S. 181
  • Willuweit, K.; Heinold, Andreas; Horn, Peter; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    Donor specific antibodies post liver transplant : Predictors and protectors
    In: Journal of Hepatology Jg. 64 (2016) Nr. 2, Suppl., S. S544
  • Willuweit, K.; Heinold, Andreas; Horn, Peter; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    Predictors and protectors of donor specific antibodies after liver transplantation
    In: Transplant International Jg. 29 (2016) Nr. Suppl. 3, S. 22
  • Willuweit, K.; Heinold, Andreas; Horn, Peter; Gerken, Guido; Paul, Andreas; Herzer, Kerstin
    Predictors for the Development of Donor Specific Antibodies After Liver Transplantation
    In: Transplantation Jg. 100 (2016) Nr. Suppl. 5, S. 238
  • Guberina, Hana; Eisenberger, Ute; Willuweit, K.; Bienholz, Anja; Kribben, Andreas; Gerken, Guido; Witzke, Oliver; Herzer, Kerstin
    Successful therapy of chronic hepatitis C virus infectionwith sofosbuvir and ledipasvir in renal transplant recipients
    In: Transplant International Jg. 29 (2016) Nr. Suppl. 3, S. 20 - 21
  • Weltermann, Birgitta; Herwig, A.; Dehnen, Dorothea; Herzer, Kerstin;
    Impfstatus von Patienten nach Lebertransplantation – Eine Querschnittsstudie
    121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,
    In: Der Internist Jg. 56 (2015) Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 64
  • Herzer, Kerstin; Welzel, T.; Spengler, U.; Hinrichsen, H.; Umgelter, A.; Gruner, N.; Klass, D.; Wiegand, J.; Zimmermann, T.; Fueloep, B.; Tacke, F.; Exposito, M. J. J.; Zeuzem, S.;
    Safety and efficacy of daclatasvir plus sofosbuvir with or without ribarivin for hepatitis C post-transplant : interim results from the compassionate use program
    24th Annual Meeting of the German Transplantation Society, 22–24 October 2015, Dresden, Germany,
    In: Transplant International Jg. 28 (2015) Nr. Suppl. 2, S. 35
  • Papadopoulos-Kohn, A.; Timm, Jörg; Canbay, Aliekber; Jochum, Christoph; Paul, Andreas; Gerken, Guido; Herzer, Kerstin;
    Daclatasvir, Simeprevir and Ribavirin as a new IFN-free triple regimen for HCV recurrence after liver transplantation : First results of safety and efficacy in 6 patients
    23rd Annual Meeting of the German Transplantation Society, Mannheim, Germany, 16–18 October 2014,
    In: Transplant International Jg. 27 (2014) Nr. Suppl. 3, S. 19
  • Papadopoulos-Kohn, A.; Timm, Jörg; Canbay, Aliekber; Jochum, Christoph; Gerken, Guido; Herzer, Kerstin
    Daclatasvir, Simeprevir and Ribavirin as a new IFN-free triple regimen for HCV recurrence after liver transplantation : First results of safety and efficacy in 6 patients
    In: Hepatology Jg. 60 (2014) Nr. Suppl. 1, S. 697A
  • Herzer, Kerstin; Mederacke, I.; Gerken, Guido; Lehner, F.; Klempnauer, J.; Manns, M. P.; Wursthorn, K.
    Reinfection prophylaxis with entecavir monotherapy is successful and safe in patients with hepatitis B virus infection after liver transplantation
    In: Hepatology Jg. 60 (2014) Nr. Suppl. 1, S. 538A
  • Ecker, E. M.; Frey, A.; Piras-Straub, K.; Walker, A.; Gerken, Guido; Herzer, Kerstin
    The influence of mTor-Inhibitors on HCV replication after liver transplantation
    In: Hepatology Jg. 60 (2014) Nr. Suppl. 1, Special Issue: The 65th Annual Meeting of the American Association for the Study of Liver Diseases, S. 533A